272 related articles for article (PubMed ID: 16553518)
1. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
[TBL] [Abstract][Full Text] [Related]
2. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
[TBL] [Abstract][Full Text] [Related]
3. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.
Greinacher A
Expert Rev Cardiovasc Ther; 2004 May; 2(3):339-57. PubMed ID: 15151481
[TBL] [Abstract][Full Text] [Related]
4. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
Fabrizio MC
J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
[TBL] [Abstract][Full Text] [Related]
5. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.
Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G
Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553
[TBL] [Abstract][Full Text] [Related]
6. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.
Koster A; Dyke CM; Aldea G; Smedira NG; McCarthy HL; Aronson S; Hetzer R; Avery E; Spiess B; Lincoff AM
Ann Thorac Surg; 2007 Feb; 83(2):572-7. PubMed ID: 17257990
[TBL] [Abstract][Full Text] [Related]
7. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.
Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T
Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738
[TBL] [Abstract][Full Text] [Related]
8. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis.
Fischer KG; van de Loo A; Böhler J
Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805
[TBL] [Abstract][Full Text] [Related]
9. Cardiac surgery in a patient with heparin-induced thrombocytopenia--cautions with use of the direct thrombin inhibitor, argatroban.
Kurup V; Transue S; Wu Y; Rinder HM; Barash P; Dewar M
Conn Med; 2006 Apr; 70(4):245-50. PubMed ID: 16768071
[TBL] [Abstract][Full Text] [Related]
10. Massive pulmonary embolism due to late-onset heparin-induced thrombocytopenia following coronary artery bypass graft surgery: successful treatment with lepirudin.
Badmanaban B; Sachithanandan A; Hunter I; Graham A; Sarsam M
J Card Surg; 2003; 18(4):316-8. PubMed ID: 12869178
[TBL] [Abstract][Full Text] [Related]
11. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
Dager WE; White RH
Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
Chamberlin JR; Lewis B; Leya F; Wallis D; Messmore H; Hoppensteadt D; Walenga JM; Moran S; Fareed J; McKiernan T
Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
[TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
Durand M; Lecompte T; Hacquard M; Carteaux JP
Eur J Cardiothorac Surg; 2008 Sep; 34(3):687-9. PubMed ID: 18579401
[TBL] [Abstract][Full Text] [Related]
14. Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.
Wahed S; Karagounis AP; Niranjan G; Kanagasabay R
J Card Surg; 2007; 22(5):424-7. PubMed ID: 17803583
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
16. Bivalirudin for anticoagulation during hypothermic cardiopulmonary bypass and recombinant factor VIIa for iatrogenic coagulopathy.
Nagle EL; Tsu LV; Dager WE
Ann Pharmacother; 2011 Sep; 45(9):e47. PubMed ID: 21862711
[TBL] [Abstract][Full Text] [Related]
17. [Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia].
Boinot C; Lanquetot H; Macchi L; Charrière JM; Menu P
Ann Fr Anesth Reanim; 2003 Jul; 22(7):635-8. PubMed ID: 12946496
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional glenn shunt surgery using lepirudin anticoagulation in an infant with heparin-induced thrombocytopenia with thrombosis.
Iannoli ED; Eaton MP; Shapiro JR
Anesth Analg; 2005 Jul; 101(1):74-6, table of contents. PubMed ID: 15976209
[TBL] [Abstract][Full Text] [Related]
19. [R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection].
Shah AC; Genoni M; Niederhäuser U; Maloigne M; Turina M
Schweiz Med Wochenschr; 2000 Jun; 130(23):896-9. PubMed ID: 10897491
[TBL] [Abstract][Full Text] [Related]
20. Routine use of the direct thrombin inhibitor bivalirudin for off-pump coronary artery bypass grafting is safe and effective.
Palmer GJ; Sankaran IS; Sparkman GM; Koster A; Dyke CM; Ebra G
Heart Surg Forum; 2008; 11(1):E24-9. PubMed ID: 18270134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
